Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-17 · accession 0001209191-23-011387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-02-21 | 2022-12-21+ | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | J - Other | $0.00 | 0 | 179.9K | New | $0 |
| M | 2023-02-21 | 2023-02-17+ | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | S - Sale | $27.23 | -27.8K | 196.2K | -12% | -$755.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-21 | J | D | 49,984 | $0.00 | 827,151 | I See footnote | — | — | (F2) The shares are held in the name of the Jennifer Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees. |
| 2 | Common | Common Stock | 2022-12-21 | J | A | 49,984 | $0.00 | 111,644 | I See footnote | — | — | (F3) The shares are held in the name of the Jennifer Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees. |
| 3 | Common | Common Stock | 2022-12-21 | J | D | 49,984 | $0.00 | 827,151 | I See footnote | — | — | (F4) The shares are held in the name of the Katherine Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees. |
| 4 | Common | Common Stock | 2022-12-21 | J | A | 49,984 | $0.00 | 111,644 | I See footnote | — | — | (F5) The shares are held in the name of the Katherine Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees. |
| 5 | Common | Common Stock | 2023-01-18 | J | D | 64,930 | $0.00 | 3,533,629 | I See footnote | — | — | (F6) The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011. |
| 6 | Common | Common Stock | 2023-01-18 | J | A | 64,930 | $0.00 | 179,930 | I See footnote | — | — | (F7) The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees. |
| 7 | Common | Common Stock | 2023-02-17 | S | D | 9,894 | $25.29 | 214,095 | D | — | — | |
| 8 | Common | Common Stock | 2023-02-21 | S | D | 11,382 | $28.02 | 202,713 | D | — | — | (F10) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.49 to $28.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2023-02-21 | S | D | 6,474 | $28.80 | 196,239 | D | — | — | (F11) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $29.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |